Nomura Healthcare Fund Q1 2026 Commentary [Seeking Alpha]
Roivant Sciences Ltd. - Common Shares (ROIV)
Company Research
Source: Seeking Alpha
Roivant Sciences Inc. advanced due to positive clinical data and a patent settlement with Moderna Inc. over lipid nanoparticle technology. Shares of Pfizer were supported by positive data points for its obesity drug pipeline and robust earnings data. The Fund's underweight position in Eli Lilly benefited relative performance, as shares consolidated following a strong run into year-end 2025. champc/iStock via Getty Images Market review Health care stocks declined during the first quarter, slightly underperforming the broader market as the escalation of the Iran conflict weighed on asset prices. Within the sector, life sciences tools and health care equipment were particularly This article was written by Quick Insights Outperformance was driven by overweight allocations to biotechnology, underweights in weak medical products/equipment sectors, and strong stock selection in pharmaceuticals like UCB SA and AstraZeneca. DLHIX remains overweight biotechnology, especially
Show less
Read more
Impact Snapshot
Event Time:
ROIV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ROIV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ROIV alerts
High impacting Roivant Sciences Ltd. - Common Shares news events
Weekly update
A roundup of the hottest topics
ROIV
News
- Could Roivant Sciences Be a Multibagger Stock Over the Next 5 Years? [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Could Roivant Sciences Be a Multibagger Stock Over the Next 5 Years? [Yahoo! Finance]Yahoo! Finance
- Here is Why Roivant (ROIV) is One of the Best Growth Stocks Trading in Oversold Territory [Yahoo! Finance]Yahoo! Finance
- Guggenheim Remains Bullish on Roivant Sciences Ltd. (ROIV) [Yahoo! Finance]Yahoo! Finance
- Baron Health Care Fund Q1 2026 Shareholder Letter [Seeking Alpha]Seeking Alpha
ROIV
Earnings
- 5/20/26 - Beat
ROIV
Sec Filings
- 7/2/26 - Form 4
- 7/2/26 - Form 4
- 7/2/26 - Form 4
- ROIV's page on the SEC website